Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions
Détails
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_70514994B951
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions
Périodique
Ann Intern Med
ISSN
1539-3704 (Electronic)
0003-4819 (Print)
0003-4819 (Print)
ISSN-L
0003-4819
Statut éditorial
Publié
Date de publication
05/2022
Peer-reviewed
Oui
Volume
175
Numéro
5
Pages
744-746
Langue
anglais
Notes
Marzolini, Catia
Kuritzkes, Daniel R
Marra, Fiona
Boyle, Alison
Gibbons, Sara
Flexner, Charles
Pozniak, Anton
Boffito, Marta
Waters, Laura
Burger, David
Back, David
Khoo, Saye
eng
MR/V020498/1/MRC_/Medical Research Council/United Kingdom
MR/V028391/1/MRC_/Medical Research Council/United Kingdom
Editorial
Research Support, Non-U.S. Gov't
Ann Intern Med. 2022 May;175(5):744-746. doi: 10.7326/M22-0281. Epub 2022 Mar 1.
Kuritzkes, Daniel R
Marra, Fiona
Boyle, Alison
Gibbons, Sara
Flexner, Charles
Pozniak, Anton
Boffito, Marta
Waters, Laura
Burger, David
Back, David
Khoo, Saye
eng
MR/V020498/1/MRC_/Medical Research Council/United Kingdom
MR/V028391/1/MRC_/Medical Research Council/United Kingdom
Editorial
Research Support, Non-U.S. Gov't
Ann Intern Med. 2022 May;175(5):744-746. doi: 10.7326/M22-0281. Epub 2022 Mar 1.
Résumé
Nirmatrelvir-ritonavir (NMV/r) is now being used to treat high-risk patients with mild to moderate COVID-19. This article provides advice to clinicians regarding recognition of medications likely to interact with NMV/r and suggests approaches to managing such drug-drug interactions. An algorithm is provided to assist in decision making.
Mots-clé
*covid-19, Drug Interactions, Humans, *Ritonavir/therapeutic use, SARS-CoV-2
Pubmed
Création de la notice
25/08/2023 6:17
Dernière modification de la notice
27/08/2023 7:12